ConductScience.org, home

Paper41766366

Turmeric (curcuma longa) rhizome essential oil: analytical profile of authenticated and commercial samples, safety and pharmacology review.

Saavedra DI and 7 others. Pharm Biol, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Turmeric (curcuma longa) rhizome essential oil: analytical profile of authenticated and commercial samples, safety and pharmacology review. Papers, record 41766366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41766366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Turmeric (curcuma longa) rhizome essential oil: analytical profile of authenticated and commercial samples, safety and pharmacology review.
PubMed
Journal
Pharm Biol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saavedra DIDiana I
2Carter DTDakota T
3Dawson JTJoseph T
4Shah SASara A
5Stevens NNicole
6Poudel AAmbika
7Satyal PPrabodh
8Bascoul CCécilehttps://orcid.org/0009-0003-2550-4694

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CurcumaMajor topic
Oils, VolatileMajor topic
RhizomeMajor topic
Drug ContaminationMajor topic
Plant OilsMajor topic
Plant ExtractsMajor topic
Animals
Humans
Gas Chromatography-Mass Spectrometry
India

Source PubMed

Download CSV of topics

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123229920Immune activation and antitumor response of ar-turmerone on P388D1 lymphoblast cell implanted tumors.Int J Mol Med2013https://conductscience.org/library/papers/23229920PubMed
237249978The role of Curcuma longa essential oil in controlling acute toxoplasmosis by improving the immune system and reducing inflammation and oxidative stress.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37249978PubMed
329316908Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.BMC Complement Altern Med2018https://conductscience.org/library/papers/29316908PubMed
433066856Effect of Turmacin supplementation on joint discomfort and functional outcome among healthy participants - A randomized placebo-controlled trial.Complement Ther Med2020https://conductscience.org/library/papers/33066856PubMed
531345163Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial.BMC Gastroenterol2019https://conductscience.org/library/papers/31345163PubMed
635893636Analysis of Volatile Constituents in Curcuma Species, viz. C. aeruginosa, C. zedoaria, and C. longa, from Nepal.Plants (Basel)2022https://conductscience.org/library/papers/35893636PubMed
721345376Development of a quantitative bioassay to assess preventive compounds against inflammation-based carcinogenesis.Nitric Oxide2011https://conductscience.org/library/papers/21345376PubMed
833041781Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications.Front Pharmacol2020https://conductscience.org/library/papers/33041781PubMed
922728094Anti-inflammatory effects of aromatic-turmerone through blocking of NF-κB, JNK, and p38 MAPK signaling pathways in amyloid β-stimulated microglia.Int Immunopharmacol2012https://conductscience.org/library/papers/22728094PubMed
1025928248Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo.Stem Cell Res Ther2014https://conductscience.org/library/papers/25928248PubMed
1129027274Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study.Phytother Res2017https://conductscience.org/library/papers/29027274PubMed
1234063571Aromatic-Turmerone Analogs Protect Dopaminergic Neurons in Midbrain Slice Cultures through Their Neuroprotective Activities.Cells2021https://conductscience.org/library/papers/34063571PubMed
1334583214
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial.
Mult Scler Relat Disord2021https://conductscience.org/library/papers/34583214PubMed
1435794287Aromatic-turmerone ameliorates DSS-induced ulcerative colitis via modulating gut microbiota in mice.Inflammopharmacology2022https://conductscience.org/library/papers/35794287PubMed
1528850308
A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.
J Med Food2017https://conductscience.org/library/papers/28850308PubMed
1620438793Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa.Food Chem Toxicol2010https://conductscience.org/library/papers/20438793PubMed
1732565848Biocurcumin as Radiosensitiser for Cervical Cancer Study (BRACES): A Double-Blind Randomised Placebo-Controlled Trial.Evid Based Complement Alternat Med2020https://conductscience.org/library/papers/32565848PubMed
1830717336Variations in the Volatile Compositions of Curcuma Species.Foods2019https://conductscience.org/library/papers/30717336PubMed
1922766494Aromatic-turmerone's anti-inflammatory effects in microglial cells are mediated by protein kinase A and heme oxygenase-1 signaling.Neurochem Int2012https://conductscience.org/library/papers/22766494PubMed
206686573Monographs on fragrance raw materials.Food Chem Toxicol1983https://conductscience.org/library/papers/6686573PubMed

See all 82 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42860821From tradition to translational medicine: advances and controversies in turmeric and curcumin research.Pharm Biol2026https://conductscience.org/library/papers/42860821PubMed
42797524Beyond the Rhizome: Phytochemistry, Biological Activities, and Sustainable Utilization of Curcuma longa L.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797524PubMed
42356474Bioactive Constituents, Mechanisms, and Complementary Therapeutic Applications of Food-Medicine Continuum Materia Medica for Atherosclerosis Prevention and Treatment.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356474PubMed
4212154910-Hydroxy-2-decenoic Acid Suppresses Colorectal Cancer Progression by Inhibiting Wnt/β-Catenin Signaling and Promoting Apoptosis.Foods2026https://conductscience.org/library/papers/42121549PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41766366

GET https://conductscience.org/api/papers/v1/41766366/references?page=2